Stockreport

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]

Aligos Therapeutics, Inc. - Common stock  (ALGS) 
PDF company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today reported recent business progress and financial result [Read more]